95 related articles for article (PubMed ID: 7537500)
1. Protein-tyrosine phosphatase inhibition by a peptide containing the phosphotyrosyl mimetic, L-O-malonyltyrosine.
Kole HK; Akamatsu M; Ye B; Yan X; Barford D; Roller PP; Burke TR
Biochem Biophys Res Commun; 1995 Apr; 209(3):817-22. PubMed ID: 7537500
[TBL] [Abstract][Full Text] [Related]
2. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp.
Burke TR; Kole HK; Roller PP
Biochem Biophys Res Commun; 1994 Oct; 204(1):129-34. PubMed ID: 7524496
[TBL] [Abstract][Full Text] [Related]
4. 4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides.
Burke TR; Ye B; Akamatsu M; Ford H; Yan X; Kole HK; Wolf G; Shoelson SE; Roller PP
J Med Chem; 1996 Mar; 39(5):1021-7. PubMed ID: 8676336
[TBL] [Abstract][Full Text] [Related]
5. Potent inhibition of protein-tyrosine phosphatase-1B using the phosphotyrosyl mimetic fluoro-O-malonyl tyrosine (FOMT).
Roller PP; Wu L; Zhang ZY; Burke TR
Bioorg Med Chem Lett; 1998 Aug; 8(16):2149-50. PubMed ID: 9873503
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of protein-tyrosine phosphatase by phosphotyrosine-mimic containing cyclic peptides.
Akamatsu M; Roller PP; Chen L; Zhang ZY; Ye B; Burke TR
Bioorg Med Chem; 1997 Jan; 5(1):157-63. PubMed ID: 9043667
[TBL] [Abstract][Full Text] [Related]
7. Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors.
Burke TR; Smyth MS; Otaka A; Nomizu M; Roller PP; Wolf G; Case R; Shoelson SE
Biochemistry; 1994 May; 33(21):6490-4. PubMed ID: 7515682
[TBL] [Abstract][Full Text] [Related]
8. Why is phosphonodifluoromethyl phenylalanine a more potent inhibitory moiety than phosphonomethyl phenylalanine toward protein-tyrosine phosphatases?
Chen L; Wu L; Otaka A; Smyth MS; Roller PP; Burke TR; den Hertog J; Zhang ZY
Biochem Biophys Res Commun; 1995 Nov; 216(3):976-84. PubMed ID: 7488220
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of phosphotyrosyl mimetic 4-(phosphonodifluoromethyl)phenylalanine (F2Pmp) into signal transduction-directed peptides.
Yao ZJ; Lee K; Burke TR
Methods Mol Biol; 2005; 298():91-103. PubMed ID: 16044542
[TBL] [Abstract][Full Text] [Related]
10. Tripeptide inhibitors of Yersinia protein-tyrosine phosphatase.
Lee K; Gao Y; Yao ZJ; Phan J; Wu L; Liang J; Waugh DS; Zhang ZY; Burke TR
Bioorg Med Chem Lett; 2003 Aug; 13(15):2577-81. PubMed ID: 12852970
[TBL] [Abstract][Full Text] [Related]
11. New syntheses of tetrazolylmethylphenylalanine and O-malonyltyrosine as pTyr mimetics for the design of STAT3 dimerization inhibitors.
Dourlat J; Valentin B; Liu WQ; Garbay C
Bioorg Med Chem Lett; 2007 Jul; 17(14):3943-6. PubMed ID: 17509878
[TBL] [Abstract][Full Text] [Related]
12. Enantioselective synthesis of (S)-3-carboxy-4-((carboxy)difluoromethyl)phenylalanine in protected form and its incorporation into a PTP-1B-directed tripeptide.
Kang SU; Gao Y; Wu L; Zhang ZY; Burke TR
Chem Biodivers; 2004 Apr; 1(4):626-33. PubMed ID: 17191873
[TBL] [Abstract][Full Text] [Related]
13. Utilization of a peptide lead for the discovery of a novel PTP1B-binding motif.
Gao Y; Voigt J; Zhao H; Pais GC; Zhang X; Wu L; Zhang ZY; Burke TR
J Med Chem; 2001 Aug; 44(18):2869-78. PubMed ID: 11520195
[TBL] [Abstract][Full Text] [Related]
14. Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic.
Combs AP; Zhu W; Crawley ML; Glass B; Polam P; Sparks RB; Modi D; Takvorian A; McLaughlin E; Yue EW; Wasserman Z; Bower M; Wei M; Rupar M; Ala PJ; Reid BM; Ellis D; Gonneville L; Emm T; Taylor N; Yeleswaram S; Li Y; Wynn R; Burn TC; Hollis G; Liu PC; Metcalf B
J Med Chem; 2006 Jun; 49(13):3774-89. PubMed ID: 16789735
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of tripeptides as potent Yersinia protein tyrosine phosphatase inhibitors.
Lee K; Boovanahalli SK; Nam KY; Kang SU; Lee M; Phan J; Wu L; Waugh DS; Zhang ZY; No KT; Lee JJ; Burke TR
Bioorg Med Chem Lett; 2005 Sep; 15(18):4037-42. PubMed ID: 16039123
[TBL] [Abstract][Full Text] [Related]
16. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors.
Burke TR; Yao ZJ; Liu DG; Voigt J; Gao Y
Biopolymers; 2001; 60(1):32-44. PubMed ID: 11376431
[TBL] [Abstract][Full Text] [Related]
17. Small molecule interactions with protein-tyrosine phosphatase PTP1B and their use in inhibitor design.
Burke TR; Ye B; Yan X; Wang S; Jia Z; Chen L; Zhang ZY; Barford D
Biochemistry; 1996 Dec; 35(50):15989-96. PubMed ID: 8973169
[TBL] [Abstract][Full Text] [Related]
18. Peptide probes containing a non-hydrolyzable phosphotyrosine-mimetic residue for enrichment of protein tyrosine phosphatases.
Tsumagari K; Niinae T; Otaka A; Ishihama Y
Proteomics; 2022 Feb; 22(4):e2100144. PubMed ID: 34714599
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibition of insulin receptor dephosphorylation by a synthetic dodecapeptide containing sulfotyrosyl residues as phosphotyrosyl mimetic.
Kole HK; Liotta AS; Garant MJ; Kole S; Bernier M
Indian J Biochem Biophys; 1997; 34(1-2):50-5. PubMed ID: 9343928
[TBL] [Abstract][Full Text] [Related]
20. A synthetic tris-sulfotyrosyl dodecapeptide analogue of the insulin receptor 1146-kinase domain inhibits tyrosine dephosphorylation of the insulin receptor in situ.
Liotta AS; Kole HK; Fales HM; Roth J; Bernier M
J Biol Chem; 1994 Sep; 269(37):22996-3001. PubMed ID: 8083198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
